Renal Allograft Recipients Clinical Trial
Official title:
A Prospective, Open-label, Multicenter, Randomized Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Renal Allograft Recipients Aged 12 to Less Than 18 Years of Age to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
The purpose of this study is to evaluate the benefits and risks of conversion of existing adolescent kidney allograft recipients aged 12 to less than 18 years of age to a belatacept-based immunosuppressive regimen as compared to continuation of a calcineurin inhibitor-based regimen and their adherence to immunosuppressive medications.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00895583 -
Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients
|
Phase 4 | |
| Completed |
NCT00470665 -
Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients
|
Phase 3 |